The research discovers a new mechanism that may help a dangerous bacterium resist a last-resort antibiotic
en-GBde-DEes-ESfr-FR

The research discovers a new mechanism that may help a dangerous bacterium resist a last-resort antibiotic


Researchers have identified an enzyme in the Staphylococcus aureus bacterium that modifies the structure of the bacterium’s cell wall and may increase its resistance to the antibiotic vancomycin. The discovery offers a new perspective on how bacteria adapt to antibiotic resistance and may help in the future to develop future strategies to combat antimicrobial resistance.

Antimicrobial resistance represents one of the major challenges facing modern medicine. Especially worrying are bacterias that develop resistance to antibiotics that are the last available treatment options.

Researchers from the Universities of Jyväskylä and Helsinki (Finland) have discovered a previously unknown mechanism by which Staphylococcus aureus, an important human pathogen, remodels its protective cell wall and responds to the antibiotic vancomycin.

A study led by Professor Perttu Permi from the University of Jyväskylä has been published in the prestigious scientific journal Nature Communications.

A new perspective on bacterial cell-wall biology

Staphylococcus aureus is particularly notorious for its ability to develop resistance to multiple antibiotics, including vancomycin, which is commonly used to treat serious infections caused by resistant staphylococci.

The study examined an enzyme called LytU, which is involved in the modification of the bacterial cell wall. The bacterial cell wall is a complex protective structure. The cell wall protects them from external stresses, maintains the cell shape and is also a target for many antibiotics. The main component of the cell wall is peptidoglycan.

The researchers discovered that LytU performs an unexpected enzymatic function.

- To our surprise, LytU did not behave like other known proteins belonging to the same enzyme family. Instead of cutting the usual bonds in peptidoglycan, it broke a specific bridge bond in the cell wall structure that plays a key role in cell wall cross-linking, explains Professor Perttu Permi of the University of Jyväskylä.

An unexpected connection to vancomycin resistance

Importantly, the study reveals that LytU activity must be tightly regulated. While increased LytU expression can enhance vancomycin resistance, excessive enzyme activity disrupts normal cell-wall construction.

In the experiments, the bacteria that produced more LytU enzyme were about 30 times more resistant to vancomycin than the control bacteria.

- What makes this discovery particularly exciting is that we have identified an enzyme that connects two seemingly opposing processes: bacterial cell-wall remodeling and antibiotic resistance. It gives us a new perspective on how Staphylococcus aureus adapts its cell wall in response to antibiotic stress, says Permi.

Although further studies are needed to establish the contribution of LytU to antibiotic resistance in clinical isolates and adapted resistant strains.

- This discovery provides a new molecular perspective on the relationship between cell-wall remodeling and antimicrobial resistance, explains Permi.

New understanding of the factors behind antibiotic resistance

The research provides new insights about how Staphylococcus aureus builds and modifies its cell wall and how the bacterium can survive under antibiotic pressure. The results show that minor modifications to the cell wall structure can affect the activity of antibiotics.

This discovery offers researchers a new perspective on bacterial defense mechanisms and may help in the future develop new strategies to fight antibiotic resistance.

Attached files
  • The study examined an enzyme called LytU. In the illustration, the LytU enzyme is shown in purple, and the substrate is salmon pink.
Regions: Europe, Finland
Keywords: Science, Chemistry, Life Sciences, Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by AlphaGalileo Terms Of Use Privacy Statement